IMVTImmunovant, Inc.

$39.52

What is the market doing?

What the tape says about IMVT

Immunovant, Inc. is +159% over the past year while the S&P 500 is +20%: 139 points ahead of the market.

+159%

1-year return · S&P 500 +20%

vs 200-day average
+33%

vs 200-day average · a clear uptrend

RSI (14)
32

RSI (14) · neutral

Below its 52-week high
12%

Below its 52-week high

2024-08-15$13.31 – $45.00 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$39.52
1 monthS&P 500 −0.30%
−0.64%
1 yearS&P 500 +20%
+159%
5 yearsS&P 500 +85%
+387%
vs 50-day average$39.32
+0.49%
52-week high
$45.00
52-week low
$14.69
Annualised volatility
57%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$13M
Calendar-year price return
YearReturn
2026 (year to date)+55%
2025+2.6%
2024−41%
2023+137%
2022+108%
2021−82%
2020+191%
Average return by calendar month, 2019–2026
MonthYearsPositiveAverage
Jan72 of 7−8.2%
Feb71 of 7−12%
Mar71 of 7−6.9%
Apr73 of 7−0.94%
May73 of 7+9.2%
Jun73 of 7−3.8%
Jul85 of 8+3.8%
Aug85 of 8+7.6%
Sep86 of 8+10%
Oct75 of 7+23%
Nov74 of 7+5.9%
Dec75 of 7+13%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.